Use of antibacterial prophylaxis in patients with chemotherapy-induced neutropenia

Current Opinion in Hematology

Volumn 19, Issue 1, 2012, Pages 21-26

  Wingard, John R ^a   Eldjerou, Lamis ^a   Leather, Helen ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Antibiotic prophylaxis; Febrile neutropenia; Neutropenic infection

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; AMIKACIN; AZACITIDINE; CARBAPENEM; CEFIXIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; LEVOFLOXACIN; PENICILLIN G; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BACTEREMIA; CENTRAL VENOUS CATHETER; CHILDHOOD LEUKEMIA; CLOSTRIDIUM DIFFICILE; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; ESCHERICHIA COLI; FEBRILE NEUTROPENIA; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MUCOSA INFLAMMATION; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; NEUTROPENIA; OVERALL SURVIVAL; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; REVIEW; STAPHYLOCOCCUS AUREUS; CHEMICALLY INDUCED DISORDER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LEUKEMIA;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; ANTINEOPLASTIC AGENTS; DRUG RESISTANCE, MICROBIAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA; MYELODYSPLASTIC SYNDROMES; NEUTROPENIA;

EID: 84856382972     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e32834da9bf     Document Type: Review

References (14)

1. Wingard JR, Elmongy M. Strategies for minimizing complications of neutropenia: prophylactic myeloid growth factors or antibiotics. Crit Rev Oncol Hematol 2009; 72:144-154.
2. Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guidelines for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2011; 52:427-431; and e56-e93.
3. Slavin MA, Lingaratnam S, Mileshkin L, et al. Use of antibacterial prophylaxis for patients with neutropenia. Intern Med J 2011; 41:102-109.
4. Shu-Ting Ng E, Liew Y, Koh LP, et al. Fluoroquinolone prophylaxis against febrile neutropenia in areas with high fluoroquinolone resistance - an Asian perspective. J Formos Med Assoc 2010; 109:624-631.
5. Eleutherakis-Papaiakovou E, Kostis E, Migkou M, et al. Prophylactic antibiotics for the prevention of neutropenic fever in patients undergoing autologous stem-cell transplantation: results of a single institution, randomized phase 2 trial. Am J Hematol 2010; 85:863-867.
6. Guthrie KA, Yong M, Frieze D, et al. The impact of a change in antibacterial prophylaxis from ceftazidime to levofloxacin in allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2010; 45:675-681.
7. Lee JH, Lee KH, Lee JH. Decreased incidence of febrile episodes with antibiotic prophylaxis in the treatment of decitabine for myelodysplastic syndrome. Leuk Res 2011; 35:499-503.
8. Rungoe C, Malchau EL, Larsen LN, Schroeder H. Infections during induction therapy for children with acute lymphoblastic leukemia. the role of sulfamethoxazole-trimethoprim (SMX-TMP) prophylaxis. Pediatr Blood Cancer 2010; 55:304-308.
9. Van Vliet MJ, Tissing WJ, Dun CA, et al. Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut. Clin Infect Dis 2009; 49:262-270.
10. Mebis J, Jansens H, Minalu G, et al. Long-term epidemiology of bacterial susceptibility profiles in adults suffering from febrile neutropenia with hematologic malignancy after antibiotic change. Infect Drug Resist 2010; 3:53-61.
11. Rangaraj G, Granwehr BP, Jiang Y, et al. Perils of quinolone exposure in cancer patients: breakthrough bacteremia with multidrug-resistant organisms. Cancer 2010; 116:967-973.
12. Therriault BL, Wilson JW, Barreto JN, Estes LL. Characterization of bacterial infections in allogeneic hematopoietic stem cell transplant recipients who received prophylactic levofloxacin with either penicillin or doxycycline. Mayo Clin Proc 2010; 85:711-718.
13. Church EC, Mauldin PD, Bosso JA. Antibiotic resistance in Pseudomonas aeruginosa related to quinolone formulary changes: an interrupted time series analysis. Infect Control Hosp Epidemiol 2011; 32:400-402.
14. Mauldin PD, Salgado CD, Hansen IS, et al. Attributable hospital cost and length of stay associated with healthcare-associated infections caused by antibiotic-resistant Gram-negative bacteria. Antimicrob Agents Chemother 2010; 54:109-115.